Tuesday, April 30, 2019

Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip - Reuters https://t.co/GgLwj69xVS


from Twitter https://twitter.com/IDROOhio

April 30, 2019 at 05:20AM

No comments:

Post a Comment